
Prasusafe 5mg Tablet
Marketer
MSN Laboratories
Salt Composition
Prasugrel (5mg)
Overview Prasusafe 5mg Tablet
CardioGuard 5mg tablets are antiplatelet agents, also known as blood thinners. They function by inhibiting harmful clot formation, ensuring consistent blood flow. This reduces the risk of recurrent heart attack or stroke in patients with cardiac conditions. CardioGuard 5mg is indicated for individuals who have recently experienced a heart attack or severe angina (unstable chest pain) and have received a coronary stent. It helps prevent major cardiovascular events such as subsequent heart attacks, strokes, or stent thrombosis. This medication may be co-administered with aspirin, another antiplatelet drug. It can be taken with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation increases the risk of cardiovascular events. The most frequent adverse effect is bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wounds may bleed more profusely and for longer durations. While generally mild and self-limiting, persistent or concerning bleeding necessitates immediate medical consultation. This medication is contraindicated in patients with active internal bleeding (e.g., gastric ulcers, intracranial hemorrhage) or severe hepatic impairment. Prior to commencing therapy, inform your physician of any history of bleeding disorders, recent major trauma, or upcoming surgery. The medication may require temporary cessation before scheduled surgical or dental procedures.
Uses of Prasusafe 5mg Tablet
Avoiding Heart Attacks and Strokes
Major Benefits of Prasusafe 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Prasusafe 5mg Tablet should be swallowed whole; do not alter its form. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Prasusafe 5mg Tablet:
- Bleeding
How to use Prasusafe 5mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Prasusafe 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Prasusafe 5mg Tablet works:
Each Prasusafe 5mg tablet contains an antiplatelet agent that inhibits platelet aggregation, thus reducing the risk of dangerous blood clot development. This action helps lower the likelihood of recurrent stroke or heart attack.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Prasusafe 5mg tablets presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Prasusafe 5mg tablets in pregnancy are unavailable. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Prasusafe 5mg Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Prasusafe 5mg Tablets.
KidneySAFE IF PRESCRIBED
Prasusafe 5mg tablets appear safe for individuals with kidney impairment. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Prasusafe 5mg Tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Data on Prasusafe 5mg Tablet use in such patients is limited. No dose alteration is advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Prasusafe 5mg Tablet :
Should you forget a Prasusafe 5mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Prasusafe 5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Piperazine-based compound |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
